Eclipse Continuity GP I, LLC - 15 Jul 2021 Form 3 Insider Report for Owlet, Inc. (OWLT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
19 Jul 2021, 20:47:19 UTC
Next SEC filing
22 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Eclipse Continuity GP I, LLC /s/ Lior Susan, Managing Member

Key filing fact

Eclipse Continuity GP I, LLC filed Form 3 for Owlet, Inc. (OWLT) on 19 Jul 2021.

Key facts

  • This page summarizes Eclipse Continuity GP I, LLC's Form 3 filing for Owlet, Inc. (OWLT).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 19 Jul 2021, 20:47.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OWLT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
13,561,716
Date
15 Jul 2021
Ownership
See footnote
Footnotes
F1, F2
OWLT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
14,930,616
Date
15 Jul 2021
Ownership
See footnote
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

On July 15, 2021, pursuant to that certain Business Combination Agreement, dated as of February 15, 2021, by and among the Issuer, Project Olympus Merger Sub, Inc. ("Merger Sub") and Owlet Baby Care Inc. ("Owlet Baby Care"), Merger Sub merged with and into Owlet Baby Care with Owlet Baby Care surviving as a wholly owned subsidiary of the Issuer (the "Merger"). Upon consummation of the Merger (the "Effective Time"), each issued and outstanding share of common stock of Owlet Baby Care was automatically cancelled and converted into approximately 2.053 (the "Exchange Ratio") shares of common stock of the Issuer.

Footnote F2

The shares of common stock are held of record by Eclipse Ventures Fund I, L.P. ("Eclipse I"). Eclipse Ventures GP I, LLC ("Eclipse I GP") is the general partner of Eclipse I and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Lior Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse I GP and may be deemed to have voting and dispositive power over the shares held by Eclipse I. Eclipse I GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse I except to the extent of their respective pecuniary interests therein, if any. Mr. Susan is a director of the Issuer and, accordingly, files separate Section 16 reports.

Footnote F3

The shares of common stock are held of record by Eclipse Continuity Fund I, L.P. ("Eclipse Continuity I"). Eclipse Continuity GP I, LLC ("Eclipse Continuity GP") is the general partner of Eclipse Continuity I and may be deemed to have voting and dispositive power over the shares held by Eclipse Continuity I. Mr. Susan, a member of the Issuer's board of directors, is the sole managing member of Eclipse Continuity GP and may be deemed to have voting and dispositive power over the shares held by Eclipse Continuity I. Eclipse Continuity GP and Mr. Susan disclaim beneficial ownership of the shares held by Eclipse Continuity I except to the extent of their respective pecuniary interests therein, if any. Mr. Susan is a director of the Issuer and, accordingly, files separate Section 16 reports.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .